• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 20-Jan-2021 14:38 PM
49,811.12
412.83 (0.84%)
NIFTY
14,652.80
131.65 (0.91%)
SENSEX
    No Companies Visited

Back to news list
  • Gland Pharma IPO subscribed 22%

    The issue received bids for 65.03 lakh shares as against 3.02 crore shares on offer.

    The initial public offer (IPO) of Gland Pharma received bids for 65.03 lakh shares on Tuesday, 10 November 2020, as against 3.02 crore shares on offer, as per the National Stock Exchange of India (NSE) website data at 17:00 IST. The issue was subscribed 0.22 times.

    The issue opened for bidding on Monday, 9 November 2020 and it will close on Wednesday, 11 November 2020. The price band for the IPO is set at Rs 1490-1500 per share.

    The IPO consists of fresh issue of shares amounting to Rs 1250 crore and an offer of sale of 3,48,63,635 shares by the selling shareholders.

    Ahead of the IPO, the Hyderabad-based generic injectables-focused company allotted 1,29,59,089 shares to 70 anchor investors at Rs 1,500 per share aggregating to Rs 1,943.86 crore.

    Overseas investors included SmallCap World Fund INC, Government of Singapore, The Nomura Trust And Banking Co and Goldman Sachs.

    Out of the total 1,29,59,089 shares allotted to anchor investors, the company allocated 43,19,700 shares (or 33.33% of the total anchor allotment portion) to 18 domestic mutual funds through a total of 77 schemes.

    The proceeds of the offer for sale shall be received by the selling shareholders. The company proposes to utilise the net proceeds of the fresh issue towards funding incremental working capital requirements; funding capital expenditure requirements; and general corporate purposes.

    The company recorded net profit of Rs 313.59 crore and total income of Rs 916.28 crore in the quarter ended on 30 June 2020.

    Hyderabad-based Gland Pharma is one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. It operates primarily under a business to business (B2B) model and it engaged in development, manufacturing and marketing of complex injectables. The company is promoted by Shanghai Fosun Pharma, a global pharmaceutical major.

    Back to news list
Previous Stories :
More

Quick Links

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
91-22-25230011
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 20-Jan-2021
  •  ( 14:32) Federal Bank Q3 PAT drops over 8% as provisions rise 2.6 times  
  •  ( 14:30) Indices near record high level  
  •  ( 13:33) European markets edges higher ahead of Joe Biden’s inauguration  
  •  ( 13:32) Nifty below 14,600; positive market breadth  
  •  ( 13:23) Tata Comm posts net profit of Rs 309.15 crore in Q3 FY21  
  •  ( 13:23) LTI Q3 PAT rises 14% QoQ to Rs 519 crore  
  •  ( 13:21) Prince Pipes receives first tranche of Rs 26.10 cr from promoter Prince Marketing  
  •  ( 13:21) IIFL Finance subsidiary signs co-lending agreement with Standard Chartered Bank  
  •  ( 13:21) Indian Bank board to mull fund raising on Jan 22  
  •  ( 13:20) Tata Steel BSL records net profit of Rs 913.19 cr in Q3 FY21  
  •  ( 12:24) Auto stocks rally for the second consecutive day  
  •  ( 12:23) The Nifty index holds its 14,600 mark; positive market breadth  
  •  ( 12:23) Indices trade in a range; India VIX down 3.81%  
  •  ( 11:36) L&T bags large order in Bangladesh  
  •  ( 11:23) Adani Green Energy commissions 150 MW solar power project in Gujarat  
  •  ( 11:23) Adani Green Energy commissions 150 MW solar power project in Kutchh, Gujarat  
  •  ( 10:56) TV18 Broadcast consol. Q3 PAT up 83.9% Y-o-Y to Rs 377.20 cr  
  •  ( 10:32) Sensex, Nifty at day's high  
  •  ( 10:12) Network18 Media & Invts. consol. Q3 PAT up 124.8% Y-o-Y to Rs 333.38 cr  
  •  ( 09:34) Strong market breadth  
  •  ( 09:31) ICICI Lombard Q3 PAT up over 6% to Rs 313.53 crore  
  •  ( 09:25) Market trading higher  
  •  ( 09:21) Shilpa Medicare CFO Sushil Bajaj resigns from position on Jan. 20  
  •  ( 08:22) China leaves benchmark lending rate unchanged  
  •  ( 08:22) Asia-Pacific stocks mostly higher  
Show News
20 January 2021 14:38
2697.55
(1.96 %)
677.70
(1.38 %)
3675.85
(0.95 %)
4970.85
(0.20 %)
8963.65
(0.46 %)
596.95
(0.75 %)
5088.40
(0.03 %)
2705.30
(1.90 %)
999.45
(1.61 %)
1493.00
(-0.69 %)
2365.30
(0.05 %)
550.65
(0.80 %)
949.65
(1.01 %)
1339.45
(1.70 %)
217.65
(-0.57 %)
1872.50
(-0.76 %)
1382.85
(0.96 %)
826.10
(2.22 %)
8081.60
(1.98 %)
17735.35
(-0.11 %)
98.45
(-1.20 %)
98.95
(0.87 %)
198.35
(-0.73 %)
2046.40
(1.49 %)
303.90
(1.77 %)
597.85
(0.27 %)
3305.75
(1.24 %)
1017.75
(2.53 %)
1536.30
(1.08 %)
5515.45
(0.49 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.